Navigation Links
Medical Industry Offers Food Ingredient Companies More Than One Billion Reasons to Think Healthy
Date:12/5/2007

NEW YORK, Dec. 5 /PRNewswire/ -- Growing price competition from low-cost manufacturers has been forcing ingredient companies to search for new ways to sustain profitable growth, which Kalorama Information predicts will likely come from the sale of products or byproducts to pharmaceutical, medical foods, or biomedical device companies -- a potential $1 billion market -- in a new report, Healthcare Opportunities for Food Ingredient Manufacturers.

Thousands of bioactive phytochemicals have potential or established pharmaceutical or medicinal applications. Food-grade pectin, used as a thickening agent and stabilizer in food, tops the industry's list of ingredients most likely to succeed in healthcare. Useful for such applications as drug delivery, gene repair, and tissue repair, pectin offers food ingredient manufacturers as much as $890 million in sales to the healthcare industry. Glycomacropeptide, a whey component that is released during the manufacture of cheese, has been shown to stimulate the body's synthesis and release of cholesystokinen. This compound plays a role in the regulation of digestion and appetite suppression, providing yet another $65.6 million market in the healthcare industry.

"There are a variety of market opportunities in the healthcare sector, either in drugs, medical foods, or medical devices," said Steven Heffner, publisher of Kalorama Information. "The cost-effective discovery and recovery of novel ingredients with improved properties from food processing streams depends on next generation analysis, isolation, and separation technologies. Food ingredient manufacturers will have to turn to science and technological advances to add value to their primary, byproduct, and waste streams."

Healthcare Opportunities for Food Ingredient Manufacturers analyzes the current and potential healthcare-related markets for some traditional food ingredients and materials, including glycomacropeptide, lactoferrin, dairy bioactives, serum protein concentrate, shell eggs, peanut skins, pectin, xanthan gum, and hydrogels. This report reviews the nature and direction of research, analyzes market opportunities for these materials in the pharmaceutical, medical foods, and biomedical device sectors, and provides an outlook on future markets. This report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Healthcare-Opportunities-Food-1468551. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.

Contact:

Tom Ehart

MarketResearch.com

240-747-3014

tehart@marketresearch.com


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: